This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Amy Bittner McCracken: Innovator in Factor XIIa Inhibitors
Introduction
Amy Bittner McCracken is a notable inventor based in Berkeley Heights, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions.
Latest Patents
Amy holds a patent for Factor XIIa inhibitors. The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability, or fibrotic changes. The compounds are selective Factor XIIa inhibitors, showcasing her innovative approach to addressing critical health issues.
Career Highlights
Amy is currently employed at Merck Sharp & Dohme Corp., where she continues to advance her research and development efforts. Her work is instrumental in creating effective treatments that can improve patient outcomes.
Collaborations
Amy has collaborated with talented individuals such as Ashwin Umesh Rao and Brian Alexander McKittrick. These partnerships enhance the innovative potential of her projects and contribute to the success of her research endeavors.
Conclusion
Amy Bittner McCracken exemplifies the spirit of innovation in the pharmaceutical industry. Her work on Factor XIIa inhibitors represents a significant advancement in medical science, and her contributions will likely have a lasting impact on patient care.